Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Expands Global Sales Force
LYON, France, Sep 24, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the expansion of its sales team operations in Italy, France, Spain and Latina America through the addition of three experienced sales
View HTML
Toggle Summary EDAP Expands Ablatherm-HIFU Into China by Entering Exclusive Distribution Agreement
Underscores Global Expansion Strategy
View HTML
Toggle Summary EDAP Expands Ablatherm-HIFU Business in Germany
Two Additional Centers Continue to Drive Revenue Per Procedure Adoption
View HTML
Toggle Summary EDAP Enhances Ablatherm-HIFU European Marketing Strategy
LYON, France, Sep 23, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the launch of an intensified communication and education strategy in France, aimed at increasing physician and patient awareness of
View HTML
Toggle Summary EDAP Elects to Pay Second Quarter Convertible Bond Interest in Cash
Strong Cash Position of EUR 15.0 million (USD 20.8 Million)
View HTML
Toggle Summary EDAP Direct De Novo for Ablatherm HIFU Replaced by 510(k)
Clearance of Predicate HIFU Technology for Ablation of Prostatic Tissue Permits Streamlined 510(k) Pathway
View HTML
Toggle Summary EDAP Delivers Focal One(R) Device for Focal Treatment of Prostate Cancer to Hospital in Poland
LYON, France , Feb. 11, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the installation of its Focal One device at the ESKULAP Private Hospital in Bydgoszcz, Poland . Focal One is the first robotic HIFU device dedicated to the focal
View HTML
Toggle Summary EDAP Continues to Expand Ablatherm-HIFU Installed Base
Dec 17, 2009 (GlobeNewswire via COMTEX News Network) -- Secures Two Ablatherm-HIFU Device Sales in Europe Finalizing Additional Sales LYON, France, Dec. 17, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that two major hospitals in
View HTML
Toggle Summary EDAP Continues Its Growth Strategy; Enters New Major Market for Lithotripsy
On Track for U.S. and Global Market Approvals
View HTML
Toggle Summary EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol
LYON, France, Jan 25, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that a meeting with the U.S. Food and Drug Administration (FDA) has been scheduled for later this month.
View HTML